Drug · DIN 02390191
CLARITHROMYCIN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 10, 2025.
- Drug Identification Number (DIN)
- 02390191
- Company (DIN owner)
- Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Clarithromycin J01FA09
- Class
- Human
- Record last updated
- June 11, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CLARITHROMYCIN | 500 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 30, 2012: NOC 13522Abbreviated New Drug Submission (ANDS) · Additional product name
Other DINs named CLARITHROMYCIN
- DIN 02442469 · Marketed
- DIN 02442485 · Marketed
- DIN 02466120 · Marketed
- DIN 02466139 · Marketed
- DIN 02390116 · Cancelled Pre Market
- DIN 02408988 · Dormant
- DIN 02408996 · Dormant